Oral Thin Films Market Analysis 2030

The Oral Thin Films Market size is predicted to reach USD 5.94 billion with a CAGR of 9.2% by 2030.

Download Free Sample

The rising chronic diseases such as diabetes, cardiovascular diseases, and Parkinson’s disease is driving the demand for effective and patientfriendly drug delivery systems including OTFs. 

North America holds the dominating in oral thin films market share at present and is projected to continue its dominance throughout the forecast period.

Oral Thin Films industry comprises of several key players such as Aquestive therapeutics Inc, IntelGenx Corp., LTS Lohmann Therapie-Systeme AG, NAL Pharma6, ZIM Laboratories limited, BioNxt Solutions Inc., Cure Pharmaceutical, BioXcel Therapeutics, MonoSol Rx, Redwood Scientific Technologies, and others.